Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.

Lutgendorf SK, Corn BW, Thaker PH, Goodheart MJ, Penedo FJ, Sood AK, Cole SW

Open source

DOI
10.1016/j.bbi.2026.107001
Published
2026 Sep 8
Container
Brain, behavior, and immunity
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbi.2026.107001,
  title = {Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.},
  author = {Lutgendorf SK and Corn BW and Thaker PH and Goodheart MJ and Penedo FJ and Sood AK and Cole SW},
  year = {2026},
  journal = {Brain, behavior, and immunity},
  doi = {10.1016/j.bbi.2026.107001},
  url = {https://doi.org/10.1016/j.bbi.2026.107001}
}

RIS

TY  - JOUR
TI  - Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.
AU  - Lutgendorf SK
AU  - Corn BW
AU  - Thaker PH
AU  - Goodheart MJ
AU  - Penedo FJ
AU  - Sood AK
AU  - Cole SW
PY  - 2026
JO  - Brain, behavior, and immunity
DO  - 10.1016/j.bbi.2026.107001
UR  - https://doi.org/10.1016/j.bbi.2026.107001
ER  - 

APA

SK, L., BW, C., PH, T., MJ, G., FJ, P., AK, S., & SW, C. (2026). Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.. Brain, behavior, and immunity. https://doi.org/10.1016/j.bbi.2026.107001

Source records